M. Gilli

Natural Killer Cells in Bal and Peripheral Blood of Patients with Idiopathic Pulmonary Fibrosis (IPF)

A. Ponticiello, A. Sanduzzi, F. Perna, 2005, International journal of immunopathology and pharmacology.

Role of FDG-PET scan in staging of pulmonary epithelioid hemangioendothelioma

V. D. Di Crescenzo, C. Vitale, A. Vatrella, 2016, Open medicine.

Gemcitabine, ifosfamide and paclitaxel in advanced/metastatic non-small cell lung cancer patients: a phase II study

G. Mazzarella, S. Marsico, F. Piantedosi, 2008, Cancer Chemotherapy and Pharmacology.

Endoscopic central airway recanalization to enable first line pembrolizumab treatment in a PD-L1 strongly positive non-small cell lung cancer: a case report

A. Fiorelli, M. Santini, F. Perrotta, 2019, Journal of Cardiothoracic Surgery.

Efficacy and safety data from patients with advanced squamous NSCLC and brain metastases participating in the nivolumab Expanded Access Programme (EAP) in Italy

A. Delmonte, R. Chiari, F. Cognetti, 2016 .

Treatments of Advanced Non‑Small Cell Lung Cancer (NSCLC) in an Italian Center: Drug Utilization and the Treatment Costs of Innovative Drugs

A. Cristinziano, F. Piantedosi, C. Battiloro, 2019, Farmeconomia. Health economics and therapeutic pathways.

Bullous pemphigoid and nivolumab: Dermatologic management to support and continue oncologic therapy.

G. Fabbrocini, L. Panariello, M. C. Annunziata, 2018, European journal of cancer.

Moving Immune Checkpoint Inhibitors to Early Non-Small Cell Lung Cancer: A Narrative Review

G. Viscardi, A. Servetto, V. Montesarchio, 2022, Cancers.

Risk factors for tuberculosis infection and disease.

A. Ponticiello, A. Sanduzzi, G. Mazzarella, 2002, Monaldi archives for chest disease = Archivio Monaldi per le malattie del torace.

Listening understanding and acting (lung): focus on communicational issue in thoracic oncology

Vito Barbieri, Paola Mazzanti, Claudia Yvonne Finocchiaro, 2019, Translational Cancer Research.